Department of Surgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA.
J Am Coll Surg. 2013 Jun;216(6):1049-56. doi: 10.1016/j.jamcollsurg.2013.01.004. Epub 2013 Mar 9.
Reliable criteria to predict mortality after hepatectomy remain poorly defined. We sought to identify factors associated with 90-day mortality, as well as validate the "50-50" and peak bilirubin of >7 mg/dL prediction rules for mortality after liver resection. In addition, we propose a novel integer-based score for 90-day mortality using a large cohort of patients.
Data from 2,056 patients who underwent liver resection at 2 major hepatobiliary centers between 1990 and 2011 were identified. Perioperative laboratory data, as well as surgical and postoperative details, were analyzed to identify factors associated with liver-related 90-day death.
Indications for liver resection included colorectal metastasis (39%), hepatocellular carcinoma (19%), benign mass (17%), or noncolorectal metastasis (14%). Most patients had normal underlying liver parenchyma (71%) and resection involved ≥3 segments (36%). Overall morbidity and mortality were 19% and 2%, respectively. Only 1 patient fulfilled the 50-50 criteria; this patient survived and was discharged on day 8. Twenty patients had a peak bilirubin concentration >7 mg/dL and 5 died within 90 days; the sensitivity and specificity of the >7-mg/dL rule were 25% and 99.3%, respectively, but overall accuracy was poor (area under the curve 0.574). Factors associated with 90-day mortality included international normalized ratio (odds ratio = 11.87), bilirubin (odds ratio = 1.16), and serum creatinine (odds ratio = 1.87) on postoperative day 3, as well as grade of postoperative complications (odds ratio = 5.08; all p < 0.05). Integer values were assigned to each factor to develop a model that predicted 90-day mortality (area under the curve 0.89). A score of ≥11 points had a sensitivity and specificity of 83.3% and 98.8%, respectively.
The 50-50 and bilirubin >7-mg/dL rules were not accurate in predicting 90-day mortality. Rather, a composite integer-based risk score based on postoperative day 3 international normalized ratio, bilirubin, creatinine, and complication grade more accurately predicted 90-day mortality after hepatectomy.
可靠的标准来预测肝切除术后死亡率仍然定义不佳。我们试图确定与 90 天死亡率相关的因素,并验证肝切除术后死亡率的“50-50”和胆红素峰值> 7mg/dL 预测规则。此外,我们使用大型患者队列提出了一种新的基于整数的 90 天死亡率评分。
从 1990 年至 2011 年间在 2 个主要肝胆中心接受肝切除术的 2056 名患者中确定了数据。分析围手术期实验室数据以及手术和术后细节,以确定与肝相关的 90 天死亡相关的因素。
肝切除术的指征包括结直肠癌转移(39%),肝细胞癌(19%),良性肿块(17%)或非结直肠癌转移(14%)。大多数患者的基础肝实质正常(71%),切除涉及≥3个节段(36%)。总体发病率和死亡率分别为 19%和 2%。只有 1 名患者符合 50-50 标准;该患者存活并在第 8 天出院。20 名患者的胆红素峰值浓度> 7mg/dL,5 名患者在 90 天内死亡;> 7mg/dL 规则的敏感性和特异性分别为 25%和 99.3%,但总体准确性较差(曲线下面积 0.574)。与 90 天死亡率相关的因素包括术后第 3 天的国际标准化比值(优势比= 11.87),胆红素(优势比= 1.16)和血清肌酐(优势比= 1.87),以及术后并发症的程度(优势比= 5.08;所有 p < 0.05)。为开发预测 90 天死亡率的模型,为每个因素分配整数值(曲线下面积 0.89)。得分≥11 分的敏感性和特异性分别为 83.3%和 98.8%。
50-50 和胆红素> 7mg/dL 规则不能准确预测 90 天死亡率。相反,基于术后第 3 天国际标准化比值,胆红素,肌酐和并发症程度的复合整数风险评分更准确地预测了肝切除术后 90 天的死亡率。